News

Gilead, Galapagos sign 10-year transformative research and development collaboration

For this collaboration, Galapagos will receive a $3.95 billion upfront payment and a $1.1 billion equity investment from Gilead.

Read More

Jul 15, 2019

By : Team ABLE

BIRAC's Biotechnology Ignition Grant Awardees annual meeting to be held on July 25th

The theme for this year is Industry Connect and BIRAC’s aim is to provide a platform to around 100 early stage startups.

Read More

Jul 12, 2019

By : Team ABLE

Glenmark & Torrent sign licensing agreement for co-marketing of Remogliflozin Etabonate in India

This agreement is an effort to widen access to the latest, novel, globally-researched drug, Remogliflozin Etabonate, indicated for treatment of Type 2 Diabetes in India

Read More

Jul 12, 2019

By : Team ABLE

Bayer, Trendlines Ag Innovation Fund to co-invest in new company EcoPhage

EcoPhage will leverage a disruptive technology for using bacteriophages, viruses that attack bacteria, for crop protection.

Read More

Jul 12, 2019

By : Team ABLE

Intas launches Romiplostim in India, an affordable treatment for Chronic Immune Thrombocytopenia

Intas Pharmaceuticals Ltd. introduces Romiplostim for the first time in India, with the brand name Romy.

Read More

Jul 10, 2019

By : Team ABLE

 

BioEconomy Conclave 2026

24th February | TAJ MG Road, Bengaluru

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Focus Areas

Highlights